Skip To Main Content
Dietlinde Janson on Muck Rack

Dietlinde Janson

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dietlinde

Contact Dietlinde, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival

|
By Kordelia Barbullushi, Nico Gagelmann, Kristin Rathje, Anita Badbaran, Johanna Richter, Mathias Schäfersküpper, Franziska E. Marquard, Radwan Massoud, Evgeny Klyuchnikov, Normann Steiner, Ina Rudolph, Silke Heidenreich, Christian Niederwieser, Catherina Lück, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger, Mirjam Reichard
| Nature Verified
Abstract Philadelphia-negative myeloproliferative neoplasms (MPNs) can progress to blast phase (MPN-BP), a biologically distinct and highly lethal entity with a median survival typically under six months. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only potentially curative approach, yet relapse and non-relapse mortality limit durable benefit. We retrospectively analyzed post-transplant outcomes in 51 consecutive adults undergoing 53 allo-HSCTs for MPN-BP.
Open in Who Shared Issue with article?

Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas

|
By Radwan Massoud, Hassan Y. Naim, Evgeny Klyuchnikov, Dietlinde Janson
| Wiley Online Library Verified
What is the new aspect of your work? A large unicentric study comparing transplant outcomes between chemorefractory and chemosensitive T-NHL. What is the central finding of your work? There is no difference in outcomes between the two groups. What is (or could be) the specific clinical relevance of your work? Allogeneic stem cell transplantation is a curative strategy for T-NHL, even in the refractory setting.
Open in Who Shared Issue with article?
See all 2 articles